
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells
Xin Yin, Laura Riva, Yuan Pu, et al.
Cell Reports (2021) Vol. 34, Iss. 2, pp. 108628-108628
Open Access | Times Cited: 347
Xin Yin, Laura Riva, Yuan Pu, et al.
Cell Reports (2021) Vol. 34, Iss. 2, pp. 108628-108628
Open Access | Times Cited: 347
Showing 1-25 of 347 citing articles:
SARS-CoV-2 pathogenesis
Mart M. Lamers, Bart L. Haagmans
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 270-284
Open Access | Times Cited: 679
Mart M. Lamers, Bart L. Haagmans
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 270-284
Open Access | Times Cited: 679
The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang, Xueru Xie, Zikun Tu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 498
Lan Yang, Xueru Xie, Zikun Tu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 498
Innate immunity: the first line of defense against SARS-CoV-2
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 492
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 492
From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways
Yaqiu Wang, Thirumala‐Devi Kanneganti
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4641-4657
Open Access | Times Cited: 312
Yaqiu Wang, Thirumala‐Devi Kanneganti
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4641-4657
Open Access | Times Cited: 312
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children
Jennifer Loske, Jobst Röhmel, Soeren Lukassen, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 3, pp. 319-324
Open Access | Times Cited: 303
Jennifer Loske, Jobst Röhmel, Soeren Lukassen, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 3, pp. 319-324
Open Access | Times Cited: 303
The interferon landscape along the respiratory tract impacts the severity of COVID-19
Benedetta Sposito, Achille Broggi, Laura Pandolfi, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4953-4968.e16
Open Access | Times Cited: 233
Benedetta Sposito, Achille Broggi, Laura Pandolfi, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4953-4968.e16
Open Access | Times Cited: 233
SARS-CoV-2 Triggers an MDA-5-Dependent Interferon Response Which Is Unable To Control Replication in Lung Epithelial Cells
Antoine Rebendenne, Ana Luiza Chaves Valadão, Marine Tauziet, et al.
Journal of Virology (2021) Vol. 95, Iss. 8
Open Access | Times Cited: 214
Antoine Rebendenne, Ana Luiza Chaves Valadão, Marine Tauziet, et al.
Journal of Virology (2021) Vol. 95, Iss. 8
Open Access | Times Cited: 214
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB
Christopher J. Neufeldt, Berati Cerikan, Mirko Cortese, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 206
Christopher J. Neufeldt, Berati Cerikan, Mirko Cortese, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 206
RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells
Taisho Yamada, Seiichi Sato, Yuki Sotoyama, et al.
Nature Immunology (2021) Vol. 22, Iss. 7, pp. 820-828
Closed Access | Times Cited: 205
Taisho Yamada, Seiichi Sato, Yuki Sotoyama, et al.
Nature Immunology (2021) Vol. 22, Iss. 7, pp. 820-828
Closed Access | Times Cited: 205
SARS‐CoV‐2 sensing by RIG‐I and MDA5 links epithelial infection to macrophage inflammation
Lucy Thorne, Ann‐Kathrin Reuschl, Lorena Zuliani‐Alvarez, et al.
The EMBO Journal (2021) Vol. 40, Iss. 15
Open Access | Times Cited: 198
Lucy Thorne, Ann‐Kathrin Reuschl, Lorena Zuliani‐Alvarez, et al.
The EMBO Journal (2021) Vol. 40, Iss. 15
Open Access | Times Cited: 198
Functional landscape of SARS-CoV-2 cellular restriction
Laura Martin‐Sancho, Mary K. Lewinski, Lars Pache, et al.
Molecular Cell (2021) Vol. 81, Iss. 12, pp. 2656-2668.e8
Open Access | Times Cited: 192
Laura Martin‐Sancho, Mary K. Lewinski, Lars Pache, et al.
Molecular Cell (2021) Vol. 81, Iss. 12, pp. 2656-2668.e8
Open Access | Times Cited: 192
Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics
Nagarjuna R. Cheemarla, Timothy A. Watkins, Valia T. Mihaylova, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 8
Open Access | Times Cited: 179
Nagarjuna R. Cheemarla, Timothy A. Watkins, Valia T. Mihaylova, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 8
Open Access | Times Cited: 179
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
Anaïs Nombel, Nicole Fabien, Frédéric Coutant
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 177
Anaïs Nombel, Nicole Fabien, Frédéric Coutant
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 177
Innate immune evasion strategies of SARS-CoV-2
Judith M. Minkoff, Benjamin R. tenOever
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 157
Judith M. Minkoff, Benjamin R. tenOever
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 157
SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy
Xingyu Li, Peili Hou, Wenqing Ma, et al.
Cellular and Molecular Immunology (2021) Vol. 19, Iss. 1, pp. 67-78
Open Access | Times Cited: 156
Xingyu Li, Peili Hou, Wenqing Ma, et al.
Cellular and Molecular Immunology (2021) Vol. 19, Iss. 1, pp. 67-78
Open Access | Times Cited: 156
The development of COVID-19 treatment
Yongliang Yuan, Baihai Jiao, Lili Qu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 150
Yongliang Yuan, Baihai Jiao, Lili Qu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 150
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
Maritza Puray‐Chavez, Kyle M. LaPak, Travis P. Schrank, et al.
Cell Reports (2021) Vol. 36, Iss. 2, pp. 109364-109364
Open Access | Times Cited: 132
Maritza Puray‐Chavez, Kyle M. LaPak, Travis P. Schrank, et al.
Cell Reports (2021) Vol. 36, Iss. 2, pp. 109364-109364
Open Access | Times Cited: 132
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates
Denisa Bojková, Marek Widera, Sandra Ciesek, et al.
Cell Research (2022) Vol. 32, Iss. 3, pp. 319-321
Open Access | Times Cited: 118
Denisa Bojková, Marek Widera, Sandra Ciesek, et al.
Cell Research (2022) Vol. 32, Iss. 3, pp. 319-321
Open Access | Times Cited: 118
The RNA sensor MDA5 detects SARS-CoV-2 infection
Natália G. Sampaio, Lise Chauveau, Jonny Hertzog, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 116
Natália G. Sampaio, Lise Chauveau, Jonny Hertzog, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 116
Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential
Bjoern Meyer, Jeanne Chiaravalli, Stacy Gellenoncourt, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 111
Bjoern Meyer, Jeanne Chiaravalli, Stacy Gellenoncourt, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 111
Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2
Catherine F. Hatton, Rachel A. Botting, María Emilia Dueñas, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 102
Catherine F. Hatton, Rachel A. Botting, María Emilia Dueñas, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 102
SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response
Yongzhen Liu, Chao Qin, Youliang Rao, et al.
mBio (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 100
Yongzhen Liu, Chao Qin, Youliang Rao, et al.
mBio (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 100
Targeting stem-loop 1 of the SARS-CoV-2 5′ UTR to suppress viral translation and Nsp1 evasion
Setu M. Vora, Pietro Fontana, Tianyang Mao, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 9
Open Access | Times Cited: 90
Setu M. Vora, Pietro Fontana, Tianyang Mao, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 9
Open Access | Times Cited: 90
SARS‐CoV‐2 ORF10 antagonizes STING‐dependent interferon activation and autophagy
Lulu Han, Yi Zheng, Jian Deng, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5174-5188
Open Access | Times Cited: 80
Lulu Han, Yi Zheng, Jian Deng, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5174-5188
Open Access | Times Cited: 80
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
Rajendra Karki, Thirumala‐Devi Kanneganti
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 72
Rajendra Karki, Thirumala‐Devi Kanneganti
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 72